Equities Research Analysts’ Updated EPS Estimates for November 13th (AMC, APEI, CRGX, DHT, DYN, EB, FEMY, FIGS, GETY, GROV)

Equities Research Analysts’ updated eps estimates for Wednesday, November 13th:

AMC Entertainment (NYSE:AMC) had its underperform rating reaffirmed by analysts at Macquarie. Macquarie currently has a $4.00 price target on the stock.

American Public Education (NASDAQ:APEI) had its target price increased by Barrington Research from $18.00 to $24.00. They currently have an outperform rating on the stock.

CARGO Therapeutics (NASDAQ:CRGX) had its buy rating reissued by analysts at Chardan Capital. Chardan Capital currently has a $28.00 price target on the stock.

DHT (NYSE:DHT) had its buy rating reiterated by analysts at Jefferies Financial Group Inc.. They currently have a $14.00 target price on the stock.

Dyne Therapeutics (NASDAQ:DYN) had its buy rating reissued by analysts at Chardan Capital. The firm currently has a $50.00 target price on the stock.

Eventbrite (NYSE:EB) had its buy rating reaffirmed by analysts at BWS Financial. The firm currently has a $7.00 target price on the stock.

Femasys (NASDAQ:FEMY) had its price target lowered by Chardan Capital from $10.00 to $8.00. The firm currently has a buy rating on the stock.

FIGS (NYSE:FIGS) had its market perform rating reissued by analysts at Telsey Advisory Group. The firm currently has a $7.00 price target on the stock.

Getty Images (NYSE:GETY) had its target price boosted by Macquarie from $3.50 to $3.75. The firm currently has a neutral rating on the stock.

Grove Collaborative (NYSE:GROV) had its outperform rating reiterated by analysts at Telsey Advisory Group. They currently have a $2.00 price target on the stock.

Lexeo Therapeutics (NASDAQ:LXEO) had its target price boosted by Chardan Capital from $23.00 to $25.00. The firm currently has a buy rating on the stock.

Marcus (NYSE:MCS) had its outperform rating reaffirmed by analysts at Barrington Research. They currently have a $24.00 price target on the stock.

Orchestra BioMed (NASDAQ:OBIO) had its buy rating reiterated by analysts at Chardan Capital. Chardan Capital currently has a $20.00 price target on the stock.

OUTFRONT Media (NYSE:OUT) had its outperform rating reiterated by analysts at Barrington Research. They currently have a $21.00 price target on the stock.

Perdoceo Education (NASDAQ:PRDO) had its price target raised by Barrington Research from $30.00 to $32.00. Barrington Research currently has an outperform rating on the stock.

Prime Medicine (NYSE:PRME) had its price target reduced by Chardan Capital from $17.00 to $15.00. Chardan Capital currently has a buy rating on the stock.

Avidity Biosciences (NASDAQ:RNA) had its buy rating reiterated by analysts at Chardan Capital. Chardan Capital currently has a $65.00 price target on the stock.

Shenandoah Telecommunications (NASDAQ:SHEN) had its buy rating reissued by analysts at BWS Financial. They currently have a $26.00 target price on the stock.

Steven Madden (NASDAQ:SHOO) had its market perform rating reiterated by analysts at Telsey Advisory Group. They currently have a $50.00 target price on the stock.

Spotify Technology (NYSE:SPOT) had its target price increased by Macquarie from $395.00 to $500.00. They currently have an outperform rating on the stock.

Target (NYSE:TGT) had its outperform rating reissued by analysts at Telsey Advisory Group. They currently have a $195.00 target price on the stock.

TJX Companies (NYSE:TJX) had its outperform rating reissued by analysts at Telsey Advisory Group. The firm currently has a $134.00 target price on the stock.

VerifyMe (NASDAQ:VRME) had its outperform rating reiterated by analysts at Barrington Research. They currently have a $1.50 target price on the stock.

Walmart (NYSE:WMT) had its outperform rating reiterated by analysts at Telsey Advisory Group. They currently have a $92.00 target price on the stock.